# Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants

Study · id `cardio:ct-nct03892824` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03892824](<https://clinicaltrials.gov/study/NCT03892824>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03892824

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT03892824. Allocation not applicable; no masking; primary purpose prevention. Start 2019-04-15 (actual); primary completion 2024-10-24 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT03892824, source copy `cardio:ctgov-nct03892824-2026-08-12`, retrieved 2026-10-26)
- Started: 2019-04-15 (actual) (ClinicalTrials.gov record NCT03892824, source copy `cardio:ctgov-nct03892824-2026-08-12`, retrieved 2026-10-26)
- Primary completion: 2024-10-24 (actual) (ClinicalTrials.gov record NCT03892824, source copy `cardio:ctgov-nct03892824-2026-08-12`, retrieved 2026-10-26)
- Completion: 2027-10-24 (anticipated) (ClinicalTrials.gov record NCT03892824, source copy `cardio:ctgov-nct03892824-2026-08-12`, retrieved 2026-10-26)
- Countries: Belgium; Czechia; Germany; Greece; Hungary; Israel; Poland; Spain (ClinicalTrials.gov record NCT03892824, source copy `cardio:ctgov-nct03892824-2026-08-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03892824-2026-08-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants
- Acronym: CAPTURE2
- Condition: Atrial Fibrillation
- Condition: Stroke
- Intervention (Device): Vine™ Embolic Protection System
- Lead sponsor: Javelin Medical
- Lead sponsor class: INDUSTRY
- Collaborator: Genae
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: fce3de5ddb79c8180c961d4215dab5fe3bde3dd20f9185228a0b6913a5d37dfc
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
